Veravas Names Streetman Jr. as Chief Executive Officer
5 August 2019 - - US-based diagnostic company Veravas, Inc has appointed Carroll E. Streetman Jr., as chief executive officer, the company said.

Streetman is a professional with over 45 years of experience.

He was president of Full Spectrum Behavior Analysis, LLC, a medical services company, and will remain on their board.

Streetman was president of DiaSorin, the global medical device manufacturing company, where he led their USD 250m in vitro diagnostics and medical device manufacturing business.

He also served as president and managing partner of CSHC Consultants, LLC where he advised public and private medical diagnostic companies on business development strategies, technology acquisition, product development, and manufacturing.

Prior to that, he was chief operating officer of HCA Healthcare Corp. where he managed and directed operations, sales, and marketing for the managed care services provider.

While at DiaSorin, Streetman worked with Josh Soldo, chief scientific officer at Veravas.

Veravas said its nano magnetic particles can identify, remove, and measure select substances from patient samples to reduce the effects of complex interferences and detect low-abundance biomarkers.